Crossject Société Anonyme

DB:74C Stock Report

Market Cap: €88.2m

Crossject Société Anonyme Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Patrick Alexandre

Chief executive officer

€233.0k

Total compensation

CEO salary percentagen/a
CEO tenure23.8yrs
CEO ownershipn/a
Management average tenureless than a year
Board average tenure5.7yrs

Recent management updates

Recent updates

CEO

Patrick Alexandre

23.8yrs

Tenure

€233,027

Compensation

Mr. Patrick Alexandre co-founded Crossject Société Anonyme (f/k/a, Crossject Medical Technology) in 2001 and has been its Chairman of the Executive Board since 2012 and serves as its Chief Executive Office...

Leadership Team

NamePositionTenureCompensationOwnership
Patrick Alexandre
Co-Founder23.8yrs€233.03kno data
Isabelle Liebschütz
Chief Quality & Regulatory Officer and Member of Executive Boardno datano datano data
Olivier Giré
COO of Specialty Pharma & Member of Executive Boardno datano datano data
Dan Chiche
Chief Medical Officer North Americaless than a yearno datano data
Tony Tipton
Chief Operating Officer of U.Sless than a yearno datano data

0.4yrs

Average Tenure

Experienced Management: 74C's management team is not considered experienced ( 0.4 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Philippe Monnot
Chairman of Supervisory Boardno datano datano data
Daniel Teper
Member of Supervisory Board1.4yrsno datano data
Eric Nemeth
Independent Vice Chairman of the Supervisory Board12.8yrsno datano data
Yannick Pletan
Member of Supervisory Board5.2yrsno datano data
Jean-Francois Loumeau
Member of Supervisory Board6.2yrsno datano data

5.7yrs

Average Tenure

Experienced Board: 74C's board of directors are considered experienced (5.7 years average tenure).